General Information of the Compound
| Compound ID |
CP0393712
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-N-[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxobutan-2-yl]-4-phenyl-2-(3-phenylpropanoylamino)butanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C36H43N7O4S
|
||||||||||||||||||
| Molecular Weight |
669.852
|
||||||||||||||||||
| Canonical SMILES |
CC[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CCc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)c1nc2ccccc2s1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C36H43N7O4S/c1-2-26(33(46)42-28(17-11-23-39-36(37)38)32(45)35-43-27-16-9-10-18-30(27)48-35)41-34(47)29(21-19-24-12-5-3-6-13-24)40-31(44)22-20-25-14-7-4-8-15-25/h3-10,12-16,18,26,28-29H,2,11,17,19-23H2,1H3,(H,40,44)(H,41,47)(H,42,46)(H4,37,38,39)/t26-,28-,29-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
OIRIOGBZIHSZJL-ZXRKZBAXSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound